Literature DB >> 17163401

Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors.

Y Takenaka1, T Tsukamoto, T Mizoshita, N Ogasawara, N Hirano, T Otsuka, H Ban, T Nakamura, Y Yamamura, M Kaminishi, M Tatematsu.   

Abstract

We have previously suggested that an origin of a stomach cancer is from a progenitor cell specializing toward exocrine cell (Exo-cell) lineages. To clarify whether our hypothesis is correct or not, we analyzed the expression of Exo-cell and endocrine cell (End-cell) markers in a series of lesions for comparison. We evaluated chromogranin A (CgA) expression in 37 early and 73 advanced stomach cancers, in 30 stomach adenomas, in 8 carcinoid tumors, and in 4 endocrine cell carcinomas (ECCs) with assessment of gastric and/or intestinal (G/I) phenotypes in both Exo-cell and End-cell by immunohistochemistry. CgA expression was observed in 10.8% of the early and 16.4% of the advanced stomach cancers, respectively. The End-cell G/I phenotypes were in line with the Exo-cell counterparts in the CgA-positive stomach cancerous areas, and there was strong association between Cdx2 expression and the intestinal End-cell markers. All of the adenoma cases had the intestinal Exo-cell phenotypic expression, with the positive link between Exo-cell and End-cell G/I phenotypes. All stomach carcinoids had CgA expression but no expression of Exo-cell markers. In conclusion, most stomach cancers might develop from a progenitor cell specializing towards Exo-cell lineages, but some cases possessed both Exo-cell and End-cell markers with maturely differentiated phenotypes. In such cases, Exo-cell and End-cell phenotypes were found to correlate strongly, suggesting the possibility of histogenesis from "cancer stem cells".

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163401     DOI: 10.14670/HH-22.273

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  3 in total

1.  Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.

Authors:  Koji Domori; Ken Nishikura; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

2.  Case of gastric neuroendocrine carcinoma showing an interesting tumorigenic pathway.

Authors:  Noriyuki Uesugi; Ryo Sugimoto; Makoto Eizuka; Yasuko Fujita; Mitsumasa Osakabe; Keisuke Koeda; Takashi Kosaka; Shunichi Yanai; Kazuyuki Ishida; Akira Sasaki; Takayuki Matsumoto; Tamotsu Sugai
Journal:  World J Clin Cases       Date:  2017-11-16       Impact factor: 1.337

3.  BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.

Authors:  Y Hirata; N Ogasawara; M Sasaki; T Mizushima; T Shimura; T Mizoshita; Y Mori; E Kubota; T Wada; S Tanida; H Kataoka; T Kamiya; S Higashiyama; T Joh
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.